Ligand validation:3UL9

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3UL9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3UL9_NAG_A_801	0%	62%	0.295	0.312	0.66	0.8	-	-	0	0	100%	0.9333
2Z65_NAG_A_1401	43%	50%	0.126	0.86	0.67	1.26	-	1	0	0	93%	0.9333
3UL7_NAG_A_801	15%	67%	0.194	0.755	0.58	0.69	-	-	0	0	100%	0.9333
3ULA_NAG_A_1201	13%	42%	0.192	0.727	1.1	1.14	1	1	0	0	100%	0.9333
3UL8_NAG_A_801	4%	67%	0.224	0.585	0.69	0.57	-	-	1	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_C_1002	100%	69%	0.022	0.994	0.55	0.65	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.